IQVIA™ Pharma Deals: Review and Analysis

IQVIA Pharma Deals Review

ISSN 1756-7874. The business journal providing incisive analysis and expert opinion on the major deals.

Pharma Deals Review Latest Articles

Eli Lilly Acquires Gene Therapy Company Prevail Therapeutics for US$1.04 B Published: 16 Apr-2021
By: Swati Sharan & Michelle Liu
Abstract Fulltext:
Volume: 2021 Issue: 4
Pfizer Pledges up to US$4.4 B for Myovant’s Orgovyx Published: 15 Apr-2021
By: Sasha Yachu & Michelle Liu
Abstract Fulltext:
Volume: 2021 Issue: 4
Roche Advances Infectious Disease Diagnostic Portfolio with US$1.8 B GenMark Acquisition Published: 9 Apr-2021
By: Debadrita Paul & Michelle Liu
Abstract Fulltext:
Volume: 2021 Issue: 4
Helsinn Boosts Oncology Portfolio with BridgeBio’s Infigratinib Published: 9 Apr-2021
By: Michelle Liu
Abstract Fulltext:
Volume: 2021 Issue: 4
Merck KGaA Expands Head and Neck Cancer Therapy Portfolio with Debiopharm’s Xevinapant Published: 2 Apr-2021
By: Debadrita Paul & Michelle Liu
Abstract Fulltext:
Volume: 2021 Issue: 4

You can click on any of the bars to open a new page with the corresponding deals.

Login

Login

Username:

Password:

Keep me logged in

Login Problems? Subscribe

Latest Article

Eli Lilly Acquires Gene Therapy Company Prevail Therapeutics for US$1.04 B

Published: 16 Apr-2021
By: Swati Sharan & Michelle Liu Abstract Fulltext:

DEAL REVIEW OF 2020

Click Here to Access the Article

IQVIA™ Pharma Deals: Review and Analysis